LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

Search

ADMA Biologics Inc

Suletud

Sektor Tervishoid

13.33 2.15

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.28

Max

13.41

Põhinäitajad

By Trading Economics

Sissetulek

35M

18M

Müük

8M

82M

Aktsiakasum

0.08

Kasumimarginaal

21.748

Töötajad

624

EBITDA

7.9M

24M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

-6.13 downside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. aug 2024

Turustatistika

By TradingEconomics

Turukapital

450M

3.1B

Eelmine avamishind

11.18

Eelmine sulgemishind

13.33

Uudiste sentiment

By Acuity

88%

12%

336 / 369 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

ADMA Biologics Inc Graafik

Seotud uudised

19. juuli 2024, 20:10 UTC

Uudisväärsed sündmused

Tech Outage Disrupts Travel, Businesses Around the World -- At a Glance

19. juuli 2024, 19:21 UTC

Suurimad hinnamuutused turgudel

Starbucks Shares Rise 5% on WSJ Report of Elliott Stake

19. juuli 2024, 22:26 UTC

Uudisväärsed sündmused

Airports Paralyzed, Flights Canceled as Microsoft Outage Sparks Worldwide Travel Chaos -- 3rd Update

19. juuli 2024, 21:54 UTC

Uudisväärsed sündmused

Major IT Outage Hits Banks, Airlines, Businesses Worldwide -- 13th Update -2-

19. juuli 2024, 21:54 UTC

Peamised uudised
Uudisväärsed sündmused

Major IT Outage Hits Banks, Airlines, Businesses Worldwide -- 13th Update

19. juuli 2024, 21:42 UTC

Tulu
Uudisväärsed sündmused

CrowdStrike Insiders Sold Stock Before the Outage. How That Happened. -- Barrons.com

19. juuli 2024, 21:20 UTC

Tulu

Tech Took Down the World on Friday. Is the Market Next? -- Barrons.com

19. juuli 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. juuli 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19. juuli 2024, 20:46 UTC

Market Talk

India Defies Slowdown in Private-Equity Exits -- Market Talk

19. juuli 2024, 20:45 UTC

Peamised uudised

Stocks Drop During Tech Outage at End of Volatile Week -- WSJ

19. juuli 2024, 20:33 UTC

Uudisväärsed sündmused

Musk Says Outage Seized Up Auto Supply Chain -- WSJ

19. juuli 2024, 20:20 UTC

Omandamised, ülevõtmised, äriostud

Activist Elliott Takes Big Stake in Starbucks -- Update

19. juuli 2024, 20:13 UTC

Peamised uudised

Heard on the Street: CrowdStrike May Get More Than a Slap -- WSJ

19. juuli 2024, 20:11 UTC

Uudisväärsed sündmused

CrowdStrike Plunges Amid IT Outage As Financial Consequences Loom -- IBD

19. juuli 2024, 19:33 UTC

Uudisväärsed sündmused

Update: Global IT Outage Hits Brokerage Firms and Wealth Managers, Including Schwab -- Barrons.com

19. juuli 2024, 19:29 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Loss -- Market Talk

19. juuli 2024, 19:22 UTC

Market Talk

Oil Futures Sink on Demand Concerns, Cyber Outage -- Market Talk

19. juuli 2024, 19:22 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Activist Elliott Takes Big Stake in Starbucks -- WSJ

19. juuli 2024, 19:06 UTC

Uudisväärsed sündmused

CrowdStrike Plunges Amid IT Outage As Financial Consequences Loom -- IBD

19. juuli 2024, 18:55 UTC

Market Talk

Fed Expected To Start Cutting Soon, Proceed Gradually -- Market Talk

19. juuli 2024, 18:38 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Activist Elliott Takes Big Stake in Starbucks -- WSJ

19. juuli 2024, 18:38 UTC

Omandamised, ülevõtmised, äriostud

Activist Investor Elliott Has Big Undisclosed Stake in Starbucks, Sources Say -- WSJ

19. juuli 2024, 18:38 UTC

Omandamised, ülevõtmised, äriostud

Elliott Pushing Starbucks Privately on Ways to Boost Stock, Sources Say -- WSJ

19. juuli 2024, 18:14 UTC

Uudisväärsed sündmused

CrowdStrike Is 'Deeply Sorry' For Windows Outage. This Time, Microsoft Isn't At Fault. -- Barrons.com

19. juuli 2024, 17:51 UTC

Peamised uudised
Uudisväärsed sündmused

Major IT Outage Hits Banks, Airlines, Businesses Worldwide -- 12th Update

19. juuli 2024, 17:48 UTC

Peamised uudised
Tulu

Amex Has A Gold Opportunity -- Heard on the Street -- WSJ

19. juuli 2024, 17:47 UTC

Peamised uudised

Government Hiring Helped Prop Up the Job Market. Now It's Set to Slow. -- Barrons.com

19. juuli 2024, 17:39 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

U.S. Oil Rig Count Falls by 1 to 477 -- Market Talk

19. juuli 2024, 17:16 UTC

Uudisväärsed sündmused

Airports Paralyzed, Flights Canceled as Microsoft Outage Sparks Worldwide Travel Chaos -- 2nd Update

Võrdlus sarnastega

Hinnamuutus

ADMA Biologics Inc Prognoos

Hinnasiht

By TipRanks

-6.13% langus

12 kuu keskmine prognoos

Keskmine 12.25 USD  -6.13%

Kõrge 15 USD

Madal 10 USD

Põhineb 4 Wall Streeti analüütiku instrumendi ADMA Biologics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

4

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

11.46 / 13.73Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

No Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

336 / 369 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest ADMA Biologics Inc

ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include ADMA BioManufacturing and Plasma Collection Centers. The Company’s ADMA BioManufacturing segment reflects its immune globulin manufacturing and development operations in Florida. The Plasma Collection Centers segment consists of approximately three plasma collection facilities. Its products include BIVIGAM, ASCENIV and Nabi-HB. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons.